Insight

CAR T-cells simultaneously targeting CD276 and FGFR4 in pediatric rhabdomyosarcoma

Photo taken from volusonclub.net

Jul 28, 2024, 12:41

CAR T-cells simultaneously targeting CD276 and FGFR4 in pediatric rhabdomyosarcoma

Katherine Masih, , shared a paper by Meijie Tian et al. on X, adding:

“Check out the latest manuscript from Javed Khan’s group describing CAR T-cells simultaneously targeting CD276 and FGFR4 in pediatric rhabdomyosarcoma out now in Nature Communications!

Huge congratulations to Meijie and the team.”

Source: Katherine Masih/X

CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma.

Authors: Meijie Tian, Jun S. Wei, Adam Tai-Chi Cheuk, David Milewski Zhongmei Zhang, Yong Yean Kim, Hsien-Chao Chou, Can Liu Sherif Badr, Eleanor G. Pope, Abdelrahman Rahmy, Jerry T. Wu, Michael C. Kelly, Xinyu Wen and Javed Khan.

Abdelrahman Rahmy Adam Tai-Chi Cheuk Can Liu Sherif Badr cancer CD276 David Milewski Zhongmei Zhang Eleanor G. Pope FGFR4 Hsien-Chao Chou Javed Khan Jerry T. Wu Jun S. Wei Katherine Masih Meijie Tian Michael C. Kelly Nature Communications OncoDaily Oncology Pediatric Rhabdomyosarcoma Stanford University School of Medicine Xinyu Wen Yong Yean Kim

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage